国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Xylella fastidiosa Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP535063XBM
CSB-EP535063XBM
CSB-BP535063XBM
CSB-MP535063XBM
CSB-EP535063XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa 50S ribosomal protein L9 (rplI) CSB-YP535064XBM
CSB-EP535064XBM
CSB-BP535064XBM
CSB-MP535064XBM
CSB-EP535064XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Dihydroorotate dehydrogenase (quinone) CSB-YP535065XBM
CSB-EP535065XBM
CSB-BP535065XBM
CSB-MP535065XBM
CSB-EP535065XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa 30S ribosomal protein S3 (rpsC) CSB-YP535066XBM
CSB-EP535066XBM
CSB-BP535066XBM
CSB-MP535066XBM
CSB-EP535066XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa 30S ribosomal protein S8 (rpsH) CSB-YP535067XBM
CSB-EP535067XBM
CSB-BP535067XBM
CSB-MP535067XBM
CSB-EP535067XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa 50S ribosomal protein L33 (rpmG) CSB-YP535068XBM
CSB-EP535068XBM
CSB-BP535068XBM
CSB-MP535068XBM
CSB-EP535068XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa 50S ribosomal protein L1 (rplA) CSB-YP535069XBM
CSB-EP535069XBM
CSB-BP535069XBM
CSB-MP535069XBM
CSB-EP535069XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Glucans biosynthesis protein D (opgD), partial CSB-YP535070XBM
CSB-EP535070XBM
CSB-BP535070XBM
CSB-MP535070XBM
CSB-EP535070XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Cell division protein FtsB (ftsB), partial CSB-YP535071XBM
CSB-EP535071XBM
CSB-BP535071XBM
CSB-MP535071XBM
CSB-EP535071XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Glutamine--tRNA ligase (glnS), partial CSB-YP535072XBM
CSB-EP535072XBM
CSB-BP535072XBM
CSB-MP535072XBM
CSB-EP535072XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Chorismate synthase (aroC) CSB-YP535073XBM
CSB-EP535073XBM
CSB-BP535073XBM
CSB-MP535073XBM
CSB-EP535073XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Protein CrcB homolog (crcB), partial CSB-YP535074XBM1
CSB-EP535074XBM1
CSB-BP535074XBM1
CSB-MP535074XBM1
CSB-EP535074XBM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Sulfite reductase [NADPH] hemoprotein beta-component (cysI), partial CSB-YP535075XBM
CSB-EP535075XBM
CSB-BP535075XBM
CSB-MP535075XBM
CSB-EP535075XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Ribose-5-phosphate isomerase A (rpiA) CSB-YP535076XBM
CSB-EP535076XBM
CSB-BP535076XBM
CSB-MP535076XBM
CSB-EP535076XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP535077XBM
CSB-EP535077XBM
CSB-BP535077XBM
CSB-MP535077XBM
CSB-EP535077XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Protein translocase subunit SecA (secA), partial CSB-YP535078MTE
CSB-EP535078MTE
CSB-BP535078MTE
CSB-MP535078MTE
CSB-EP535078MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP535079MTE
CSB-EP535079MTE
CSB-BP535079MTE
CSB-MP535079MTE
CSB-EP535079MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. 30S ribosomal protein S16 (rpsP) CSB-YP535080MTE
CSB-EP535080MTE
CSB-BP535080MTE
CSB-MP535080MTE
CSB-EP535080MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Probable transcriptional regulatory protein M446_6579 (M446_6579) CSB-YP535081MTE
CSB-EP535081MTE
CSB-BP535081MTE
CSB-MP535081MTE
CSB-EP535081MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (bchL) CSB-YP535082MTE
CSB-EP535082MTE
CSB-BP535082MTE
CSB-MP535082MTE
CSB-EP535082MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>